Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2020-08-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by KDB Capital and its special related parties in SCM Lifescience Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant share ownership levels.
2020-08-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS), as it reports personal share transactions and ownership status by a company executive.
2020-07-27 Korean
[기재정정]증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by SCM Life Science Co., Ltd. It details the final results of a public offering, including subscription and allocation status, use of proceeds, and changes in shareholding. This type of filing is a standard regulatory disclosure regarding capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-07-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder changes their shareholding position. This falls under the category of Director's Dealing (DIRS), which covers insider transactions and changes in ownership by company insiders.
2020-07-16 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and details the outcomes of specific agenda items (election of a director and stock option grants) from a shareholder meeting held on 2020-06-30. This falls under the category of official results from shareholder votes at a general meeting.
2020-06-30 Korean
본점소재지변경
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details about the old and new addresses, the reason for the change, and the effective date. Since this is a standard corporate regulatory disclosure that does not fit into specific categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2020-06-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.